Molecular Loop Biosciences, a Woburn, MA-based provider of targeted sequencing technologies, received a $1.8M grant from the Bill & Melinda Gates Foundation.
The company intends to use the grant to develop and evaluate a multiplex NGS assay for the genomic analysis of the causative agents of respiratory infections.
Led by CEO and PhD Greg Porreca, Molecular Loop tailors customized targeted sequencing solutions using its technology that delivers workflow simplicity without sacrificing data quality. The company leverages its technology and deep genomic expertise to accelerate innovations in life sciences and make advancements in personalized healthcare.
Through strategic partnerships and innovative technology, Molecular Loop aims to overcome technical barriers of existing methodologies and empower laboratories in LMICs to actively participate in global viral surveillance efforts.
FinSMEs
13/12/2023